Unlock all Features See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Mallinckrodt
Express Scripts
Moodys
Merck
Baxter

Last Updated: October 7, 2022

GLYCINE 1.5% IN PLASTIC CONTAINER Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Which patents cover Glycine 1.5% In Plastic Container, and what generic alternatives are available?

Glycine 1.5% In Plastic Container is a drug marketed by B Braun, Baxter Hlthcare, Hospira, and Icu Medical Inc. and is included in four NDAs.

The generic ingredient in GLYCINE 1.5% IN PLASTIC CONTAINER is glycine. There are thirty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the glycine profile page.

Drug patent expirations by year for GLYCINE 1.5% IN PLASTIC CONTAINER
Recent Clinical Trials for GLYCINE 1.5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsPhase 1
All India Institute of Medical Sciences, BhubaneswarPhase 4
Kayseri City HospitalPhase 3

See all GLYCINE 1.5% IN PLASTIC CONTAINER clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for GLYCINE 1.5% IN PLASTIC CONTAINER

US Patents and Regulatory Information for GLYCINE 1.5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun GLYCINE 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 016784-001 Approved Prior to Jan 1, 1982 AT RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Icu Medical Inc GLYCINE 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 018315-001 Approved Prior to Jan 1, 1982 AT RX No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
Baxter Hlthcare GLYCINE 1.5% IN PLASTIC CONTAINER glycine SOLUTION;IRRIGATION 018522-001 Feb 19, 1982 DISCN No No See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Medtronic
AstraZeneca
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.